160
Participants
Start Date
March 23, 2020
Primary Completion Date
January 4, 2023
Study Completion Date
February 23, 2023
aldafermin
aldafermin
Placebo
Placebo for aldafermin
NGM Clinical Study Site, Baltimore
NGM Clinical Study Site, Richmond
NGM Clinical Study Site, Richmond
NGM Clinical Study Site, Durham
NGM Clinical Study Site, Marietta
NGM Clinical Study Site, Miami
NGM Clinical Study Site, Boca Raton
NGM Clinical Study Site, Pessac
NGM Clinical Study Site, Germantown
NGM Clinical Study Site 488, Jackson
NGM Clinical Study Site, Flowood
NGM Clinical Study Site, Chicago
NGM Clinical Study Site, Chicago
NGM Clinical Study Site, Kansas City
NGM Clinical Study Site, North Little Rock
NGM Clinical Study Site 481, Houston
NGM Clinical Study Site, San Antonio
NGM Clinical Study Site, Edinburg
NGM Clinical Study Site, San Antonio
NGM Clinical Study Site, Edinburg
NGM Clinical Study Site, Austin
NGM Clinical Study Site, Glendale
NGM Clinical Study Site 413, Tucson
NGM Clinical Study Site 415, Tucson
NGM Clinical Study Site, Los Angeles
NGM Clinical Study Site, Panorama City
NGM Clinical Study Site, La Jolla
NGM Clinical Study Site, Rialto
NGM Clinical Study Site, Fresno
NGM Clinical Study Site 482, Seattle
NGM Clinical Study Site, Boston
NGM Clinical Study Site, Boston
NGM Clinical Study Site, Camperdown
NGM Clinical Study Site, Westmead
NGM Clinical Study Site, Adelaide
NGM Clinical Study Site, Bedford Park
NGM Clinical Study Site, Clayton
NGM Clinical Study Site, Fitzroy
NGM Clinical Study Site, Heidelberg
NGM Clinical Study Site, Melbourne
NGM Clinical Study Site, Brussels
NGM Clinical Study Site, Paris
NGM Clinical Study Site, Leipzig
NGM Clinical Study Site, Shatin
NGM Clinical Study Site 444, Wroclaw
NGM Clinical Study Site 446, Wroclaw
NGM Clinical Study Site 466, London
NGM Clinical Study Site, Leipzig
NGM Clinical Study Site, San Juan
Lead Sponsor
NGM Biopharmaceuticals, Inc
INDUSTRY